The price you pay for Wegovy (semaglutide) may depend on factors such as your dosage, whether you have health insurance coverage, and the pharmacy you use. Financial assistance may be available to ...

Clalit Health Services announced on Monday that it will subsidize the long-standing Wegovy injection by 50%. This comes after both Maccabi and Meuhedet Health Services announced the same subsidy ...

The cost of Wegovy without insurance depends on various factors. These include your treatment plan, your dosage, and the pharmacy you use. You may get financial assistance to help with Wegovy’s ...

Over the last year, weight loss jabs have become highly popular, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. There has also ...

Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from “Neutral” to “Buy.” Novo Nordisk markets its semaglutide ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications. According ...

The global injection pen industry is projected to experience robust growth over the next decade, with its valuation rising from USD 40.7 billion in 2022 to USD 85.8 billion by 2033. This reflects a ...

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug CagriSema, wiping as much as $125 billion off its market value.

Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a scientist who developed the revolutionary drugs has said. Professor ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. This time last year ...